University of Washington
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).
University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.
University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.
Top-decile sponsor footprint
University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,048 total, page 6 of 21
The Effect of Immersive VR Distraction on Memory: Study 2
NCT07183839
A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery
NCT05316688
Decision Making Tool for Firearm Storage
NCT06382194
Feasibility Trial Using an Inpatient Insulin Dosing Calculator
NCT06206525
Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington
NCT06187064
Stress-motivated Alcohol Use as a Value-based Decision-making Process
NCT06264791
Digital Clinical Hypnosis for Chronic Pain Management
NCT06050083
Culturally-Responsive Curriculum for Caregivers With Children at Autism Likelihood
NCT06314438
Prospective Case Series to Refine Standalone Cognitive Behavioral Therapy Components for Multiple Sclerosis Fatigue
NCT05848323
Stroke and CPAP Outcome Study 3
NCT06029959
Digital Therapeutic for Chronic Pain Feasibility Study
NCT06000007
Quantifying Energetic Demands of Walking for People With Cerebral Palsy
NCT04303078
Bolster: Caregiver App to Reduce Duration of Untreated Psychosis
NCT04949542
Technology-Assisted Implementation of a Mobile Health Program for Serious Mental Illness
NCT05725785
PRISM Race and Communication Pilot RCT
NCT04915079
Pharmacy Transitional Team: Evaluating the Value for Patients With Limited English Proficiency
NCT07437508
Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer
NCT05847686
Social Safety Learning in the Brain Oxytocin System
NCT05968651
mHealth for Psychosis Help-seeking
NCT05905601
Pilot Mobile for Dementia and Frailty
NCT05827094
Testing Brief Personalized Feedback Integrating Lab-based Alcohol Cue Information
NCT05873556
Virtual Training for Latino Caregivers to Manage Symptoms of Dementia
NCT05599100
VOCALE LBD+ for Caregivers of Persons With Lewy Body Dementia
NCT05622734
Cubii for Exercise in People With MS
NCT05826431
MBCT Intervention: Healthy Mind, Healthy Living
NCT05965349
First in Human Study of TLC-ART 101 (ACTU 2001)
NCT05850728
Assessing and Promoting Resilience in Patients With Adult Congenital Heart Disease
NCT04738474
A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease
NCT05651542
Sub-Ischial Socket for Transfemoral Amputation and Lower Mobility
NCT05662982
Deprescribing to Reduce Injurious Falls Among Older Adults With Dementia
NCT05777772
Music-based Treatments and Pain: Underlying Mechanisms and the Beneficial Effects of Music-Based Treatments
NCT05578781
The COPE Study: Pilot Intervention to Improve Symptom Self-management and Coping in Adults With Post COVID-19
NCT05658536
Does What You Eat Affect Your Brain
NCT05626907
Diabetes Education With Real-time Continuous Glucose Monitoring
NCT05394844
Olaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma
NCT04951492
Effect of Estrogen Treatment on Drug Metabolism and Transport
NCT05469204
CBT Texts for PTSD & Hazardous Drinking (Project Better)
NCT05372042
TRIAD Appendicitis Decision-making Surveys
NCT05887414
Reopening Schools Safely and Educating Youth Research- Early Learning Ancillary Study
NCT05965323
Using Immersive Virtual Reality to Treat Complex Regional Pain Syndrome in Adults
NCT05888142
Journey of Transformation Curriculum for Native American Adolescents
NCT05274217
Reducing Sugared Fruit Drinks in Alaska Native Children
NCT05219448
Helping Educational Leadership Mobilize Evidence
NCT06340074
Design of Chatbot Persona for Breast Cancer Screening Outreach Among Black Women
NCT05472064
Optimizing Implementation Coaching to Support Successful EBP Delivery
NCT05799794
Cancer Parenting Program for the Enhancement of the Quality of Life of Patients With Advanced Cancer and Their Children
NCT05477784
Do Terpenes Play a Role in the Stress-reducing Effects of a Forest Bathing Intervention?
NCT05316597
Optimizing Video Communication Assessment for Teaching Error Disclosure Skills
NCT06234085
CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language Technologies
NCT05127837
Thermotape High-adhesion Medical Tape Comparison Study
NCT05449600
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 127 |
| Phase 2 | 193 |
| Phase 3 | 39 |
| Phase 4 | 65 |
What is open in the University of Washington pipeline
156 recruiting of 1,048 indexed (15% open); 720 completed (69%).
Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).
Top condition: Depression (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Washington: open-pipeline peers nationwide
Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,048 trials (± recruiting share)
- University of Wisconsin, Madison · 1,039 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Arizona State University · 15% recruiting · 187 trials
- Georgetown University · 15% recruiting · 227 trials
Related
What to do with this University of Washington page
1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.
- 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.